Patent US4454119A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4454119A Expired / Lapsed US ⏱️ 0.0 years remaining

Therapeutic agents

Assignee: Mitsubishi Chemical Corp
•
Filing: 1981-06-29
•
Granted: 1984-06-12
•
Expires: 2001-06-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A therapeutic agent comprising an oil-in-water type suspension of an alkali treated lipopolysaccharide from gram negative bacteria and cord factor of acid fast bacteria or its similar substance of corynebacteria.

Inventors

  • 👤 Kazue Fukushi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 09:17
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/66; A61K35/74; A61K31/00; A61K31/70; A61K31/715; C; C12; C12P; C12P19/00; C12P19/12

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 44 words
A therapeutic agent comprising an oil-in-water suspension of (A) an alkali treated lipopolysaccharide from gram negative bacteria and (B) a cord factor of acid fast bacteria or its similar substance of corynebacteria, the proportions of (A) to (B) being 20:1 to 1:2 by weight.
Claim 2
Dependent Claim 44 words
A therapeutic agent comprising an oil-in-water suspension of (A) an alkali treated lipopolysaccharide from gram negative bacteria and (B) a cord factor of acid fast bacteria or its similar substance of corynebacteria, the proportions of (A) to (B) being 20:1 to 1:2 by weight.
Claim 3
Dependent Claim 16 words
The therapeutic agent of claim 1, wherein the gram negative bacteria are gram negative rods bacteria.
Claim 4
Dependent Claim 13 words
The therapeutic agent of claim 2, wherein the gram negative bacteria are Salmonella.
Claim 5
Dependent Claim 17 words
The therapeutic agent of claim 3, wherein the gram negative bacteria are Salmonella minnesota or Salmonella typhimurium.
Claim 6
Dependent Claim 13 words
The therapeutic agent of claim 2, wherein the gram negative bacteria are Serratia.
Claim 7
Dependent Claim 14 words
The therapeutic agent of claim 5, wherein the gram negative bacteria are Serratia marcescens.
Claim 8
Dependent Claim 13 words
The therapeutic agent of claim 2, wherein the gram negative bacteria are Escherichia.
Claim 9
Dependent Claim 14 words
The therapeutic agent of claim 7, wherein the gram negative bacteria are Escherichia coli.
Claim 10
Dependent Claim 16 words
The therapeutic agent of claim 1, wherein the lipopolysaccharide is treated by hydroxylamine or alkaline hydroxylamine.
Claim 11
Dependent Claim 18 words
The therapeutic agent of claim 1, wherein the suspension contains the cord factor of the acid fast bacteria.
Claim 12
Dependent Claim 13 words
The therapeutic agent of claim 10, wherein the acid fast bacteria are Mycobacterium.
Claim 13
Dependent Claim 25 words
The therapeutic agent of claim 11, wherein the acid fast bacteria are selected from the group consisting of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis.
Claim 14
Dependent Claim 17 words
The therapeutic agent of claim 1, wherein a mineral oil is used to prepare the oil-in-water suspension.
Claim 15
Dependent Claim 19 words
The therapeutic agent of claim 13 wherein the proportions of (A) to (B) are 6:1 to 1:1 by weight.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-12 1987-12-12 1988-06-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-12 1991-12-12 1992-06-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-12 1995-12-12 1996-06-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag